R&D

Breaking News | Collaborations & Alliances | R&D

Roche, Shape Therapeutics Enter Strategic Gene Therapy Collaboration

ShapeTX will apply its RNA editing platform and leverage its AAVid technology platform for the development of gene therapy for various diseases.

08.25.21

Breaking News | R&D

Amgen, USC Provide Researchers Access to Thermo Scientific Cryo-EMs

Access to Krios and Glacios microscopes allows researchers from both institutions to combine resources to bring more speed and power to their research.

08.10.21

Breaking News | Drug Development | R&D

Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs

Aim to discover new possibilities for cancer treatment in the shortest-possible time.

08.10.21

Breaking News | R&D

Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

The appointment forms part of the company’s growth strategy for 2021 and 2022, with a focus on the USA, EU and Japan.

07.26.21

Aptamer and WuXi AppTec Form Research Partnership

Collaborate to identify new Optimer-enabled therapeutics.

07.22.21

BioMed X Expands Collaboration with Merck

Launches a new joint research program in oncology.

07.06.21

Analytical Services | Laboratory Testing | R&D

Improving the Efficiency of Routine LC-MS/MS Assay with Multiplex UHPLC Platform

LC-MS/MS shows enormous capabilities for increasing sample throughput by monitoring multiple analytes simultaneously.

Sponsored released by Shimadzu Scientific Instruments 06.24.21

Analytical Services | Bioanalytical Services | Drug Development | Laboratory Testing | R&D

CRO Industry Update

Digital modernization, decentralized trials and advanced therapies drive outsourcing.

Kristin Brooks, Managing Editor, Contract Pharma 06.07.21

R&D Alliance for Eye Disease Cell Therapies

BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics enter R&D pact to discover and develop cell therapies for eye diseases.

Tim Wright, Editor, Contract Pharma 05.17.21

BioMedX Extends Collaboration with Merck

Merck will support up to six more research groups at the BioMed X Institute in Heidelberg within the next six years.

Charles Sternberg, Assistant Editor 05.17.21

Breaking News | Drug Development | R&D

Crown Bioscience Acquires OcellO

Expands its portfolio of in vitro services.

Charles Sternberg, Assistant Editor 05.06.21

Albumedix Extends Research Collaboration with Cobra Biologics

Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.

Tim Wright, Editor, Contract Pharma 05.03.21

AMRI Adds R&D and Mfg. Solutions for Orphan Products

Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.

Kristin Brooks 04.30.21

Clinical Trials | R&D | Regulatory Affairs

Unifying Quality Manufacturing to Drive Speed, Collaboration, and Compliance

Learn how you can unify end-to-end quality management to improve visibility, efficiency, and compliance in this webinar on May 13.

04.22.21

R&D

Digitalization and the Future of Formulating in Modern R&D Labs

This webinar will focus on the benefits of implementing a true data infrastructure, and the challenges that organizations will face along this journey.

04.12.21

R&D